Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Extracorporeal Circulation | 3 | 2021 | 130 | 1.71 | Why? |
| Invasive Pulmonary Aspergillosis | 2 | 2021 | 634 | 1.01 | Why? |
| Mannans | 2 | 2021 | 218 | 0.95 | Why? |
| Multiple Organ Failure | 2 | 2021 | 1724 | 0.83 | Why? |
| Thermodilution | 4 | 2021 | 62 | 0.83 | Why? |
| Lipase | 1 | 2020 | 153 | 0.77 | Why? |
| Pancreatitis, Acute Necrotizing | 1 | 2018 | 47 | 0.72 | Why? |
| Carbon Dioxide | 2 | 2021 | 917 | 0.67 | Why? |
| beta-Glucans | 1 | 2017 | 176 | 0.57 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.53 | Why? |
| Candidemia | 1 | 2018 | 353 | 0.53 | Why? |
| Pneumonia, Pneumocystis | 1 | 2017 | 322 | 0.48 | Why? |
| Renal Dialysis | 2 | 2021 | 4358 | 0.47 | Why? |
| Liver Cirrhosis | 3 | 2018 | 1810 | 0.42 | Why? |
| Galactose | 2 | 2021 | 201 | 0.41 | Why? |
| Respiration, Artificial | 6 | 2021 | 22116 | 0.38 | Why? |
| Hemodynamics | 4 | 2020 | 1562 | 0.33 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.28 | Why? |
| Extravascular Lung Water | 2 | 2021 | 32 | 0.27 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.25 | Why? |
| Acute Kidney Injury | 2 | 2020 | 5762 | 0.24 | Why? |
| Arterial Pressure | 2 | 2020 | 208 | 0.23 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 2309 | 0.22 | Why? |
| Pancreatitis | 2 | 2020 | 688 | 0.22 | Why? |
| Critical Illness | 6 | 2021 | 17281 | 0.20 | Why? |
| Capillary Permeability | 2 | 2021 | 277 | 0.20 | Why? |
| Pulmonary Edema | 2 | 2021 | 430 | 0.19 | Why? |
| Indocyanine Green | 1 | 2019 | 66 | 0.19 | Why? |
| Mucosal-Associated Invariant T Cells | 1 | 2021 | 170 | 0.19 | Why? |
| Leptospirosis | 1 | 2019 | 103 | 0.18 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 5002 | 0.18 | Why? |
| Pancreatic Pseudocyst | 1 | 2017 | 23 | 0.18 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.16 | Why? |
| Cardiac Output | 1 | 2017 | 183 | 0.16 | Why? |
| Vasoconstrictor Agents | 1 | 2020 | 714 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Proteoglycans | 1 | 2017 | 130 | 0.16 | Why? |
| Superinfection | 1 | 2021 | 459 | 0.15 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 237 | 0.15 | Why? |
| Aged | 16 | 2021 | 215776 | 0.14 | Why? |
| Alcoholic Beverages | 1 | 2017 | 186 | 0.14 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.13 | Why? |
| Lung | 3 | 2021 | 31049 | 0.13 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.13 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.13 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.12 | Why? |
| Catheterization, Central Venous | 1 | 2017 | 458 | 0.12 | Why? |
| Liver Function Tests | 1 | 2019 | 1325 | 0.12 | Why? |
| Antimicrobial Stewardship | 1 | 2020 | 931 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 800 | 0.12 | Why? |
| Male | 18 | 2021 | 367725 | 0.11 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.11 | Why? |
| Female | 18 | 2021 | 380317 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.11 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.10 | Why? |
| Monitoring, Physiologic | 2 | 2021 | 1956 | 0.10 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.09 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.09 | Why? |
| Stroke Volume | 1 | 2017 | 2153 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2019 | 2654 | 0.08 | Why? |
| Humans | 21 | 2021 | 930598 | 0.08 | Why? |
| Bacterial Infections | 1 | 2020 | 2229 | 0.08 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.08 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.08 | Why? |
| Adult | 10 | 2021 | 244371 | 0.08 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.08 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.07 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.07 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.07 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2021 | 243684 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Liver Diseases | 1 | 2019 | 2698 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| Sulbactam | 1 | 2020 | 37 | 0.06 | Why? |
| Ampicillin | 1 | 2020 | 73 | 0.05 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Granzymes | 1 | 2021 | 197 | 0.05 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.05 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.05 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Linezolid | 1 | 2020 | 160 | 0.05 | Why? |
| Hyperbilirubinemia | 1 | 2019 | 81 | 0.05 | Why? |
| Catecholamines | 1 | 2019 | 66 | 0.05 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.05 | Why? |
| Paracentesis | 1 | 2018 | 25 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.05 | Why? |
| Coloring Agents | 1 | 2019 | 116 | 0.05 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.04 | Why? |
| Femoral Vein | 1 | 2017 | 43 | 0.04 | Why? |
| Pancreatitis, Chronic | 1 | 2017 | 37 | 0.04 | Why? |
| Vancomycin | 1 | 2020 | 328 | 0.04 | Why? |
| Jugular Veins | 1 | 2017 | 52 | 0.04 | Why? |
| Radiography, Abdominal | 1 | 2017 | 88 | 0.04 | Why? |
| Streptococcal Infections | 1 | 2020 | 255 | 0.04 | Why? |
| Ceftriaxone | 1 | 2019 | 365 | 0.04 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.04 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.04 | Why? |
| Aspergillosis | 1 | 2020 | 264 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Escherichia coli Infections | 1 | 2020 | 348 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2017 | 381 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2019 | 520 | 0.04 | Why? |
| Doxycycline | 1 | 2019 | 307 | 0.04 | Why? |
| Esophagus | 1 | 2018 | 139 | 0.04 | Why? |
| APACHE | 1 | 2019 | 682 | 0.04 | Why? |
| Pressure | 1 | 2018 | 289 | 0.04 | Why? |
| Interleukin-17 | 1 | 2021 | 602 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.04 | Why? |
| Klebsiella Infections | 1 | 2020 | 466 | 0.04 | Why? |
| Germany | 2 | 2021 | 9196 | 0.04 | Why? |
| Tidal Volume | 1 | 2018 | 565 | 0.04 | Why? |
| Enterobacteriaceae Infections | 1 | 2020 | 529 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.03 | Why? |
| Drainage | 1 | 2017 | 414 | 0.03 | Why? |
| Respiratory Mechanics | 1 | 2018 | 585 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2019 | 1329 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.03 | Why? |
| Staphylococcal Infections | 1 | 2020 | 1099 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.03 | Why? |
| Antifungal Agents | 1 | 2020 | 1828 | 0.02 | Why? |
| Alcoholism | 1 | 2017 | 691 | 0.02 | Why? |
| Positive-Pressure Respiration | 1 | 2018 | 1160 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Endoscopy | 1 | 2017 | 1564 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.01 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2018 | 7301 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
Lahmer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(181)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_